Professional Documents
Culture Documents
LIVER FIBROSIS
Background: Transient elastography (FibroScan) is a new, non-invasive, rapid, and reproducible method
allowing evaluation of liver fibrosis by measurement of liver stiffness. In cirrhotic patients, liver stiffness
measurements range from 12.5 to 75.5 kPa. However, the clinical relevance of these values is unknown.
See end of article for The aim of this prospective study was to evaluate the accuracy of liver stiffness measurement for the
authors’ affiliations detection of cirrhosis in patients with chronic liver disease.
....................... Methods: A total of 711 patients with chronic liver disease were studied. Aetiologies of chronic liver
Correspondence to: diseases were hepatitis C virus or hepatitis B virus infection, alcohol, non-alcoholic steatohepatitis, other,
Professor V de Lédinghen, or a combination of the above aetiologies. Liver fibrosis was evaluated according to the METAVIR score.
Service d’Hépato- Results: Stiffness was significantly correlated with fibrosis stage (r = 0.73, p,0.0001). Areas under the
Gastroentérologie, Hôpital
Haut Lévêque, Avenue
receiver operating characteristic curve (95% confidence interval) were 0.80 (0.75–0.84) for patients with
Magellan, 33604 Pessac, significant fibrosis (F.2), 0.90 (0.86–0.93) for patients with severe fibrosis (F3), and 0.96 (0.94–0.98) for
France; victor. patients with cirrhosis. Using a cut off value of 17.6 kPa, patients with cirrhosis were detected with a
deledinghen@ positive predictive value and a negative predictive value (NPV) of 90%. Liver stiffness was significantly
chu-bordeaux.fr
correlated with clinical, biological, and morphological parameters of liver disease. With an NPV .90%,
Revised version received the cut off values for the presence of oesophageal varices stage 2/3, cirrhosis Child-Pugh B or C, past
16 May 2005 history of ascites, hepatocellular carcinoma, and oesophageal bleeding were 27.5, 37.5, 49.1, 53.7, and
Accepted for publication 62.7 kPa, respectively.
22 June 2005
Published online first Conclusion: Transient elastography is a promising non-invasive method for detection of cirrhosis in
14 July 2005 patients with chronic liver disease. Its use for the follow up and management of these patients could be of
....................... great interest and should be evaluated further.
P
rogressive hepatic fibrosis with the development of modulus). The harder the tissue, the faster the shear wave
cirrhosis is a feature of almost all chronic liver diseases. propagates. Recent reports have shown that liver stiffness
Approximately 10–20% of patients with chronic hepatitis measurement using FibroScan allowed accurate prediction of
C virus infection have cirrhosis at first clinical presentation, hepatic fibrosis in patients with chronic hepatitis C virus
and as many 20–30% of those who do not have cirrhosis will infection.11–14 In patients with chronic hepatitis C, we have
eventually develop this condition and its complications shown that liver stiffness measurements ranged from 2.4 to
within one or more decades.1–3 These complications are liver 75 kPa, with a median value of 7.4 kPa.14 Based on the
failure, ascites, variceal bleeding, portal-systemic encephalo- stiffness measurement distribution according to fibrosis stage
pathy, and hepatocellular carcinoma.3 and receiver operating characteristic (ROC) curves, we found
Liver biopsy is currently considered the gold standard for that the cut off value for cirrhosis was 12.5 kPa. However, the
assessing hepatic fibrosis. However, it is an invasive and clinical relevance of theses values (from 12.5 to 75 kPa) in
painful procedure,4 with rare but potential life threatening cirrhotic patients is unknown.
complications,5 limiting its acceptance and repetition in The aim of this prospective study was to assess the
usually asymptomatic patients. In addition, the accuracy of accuracy of transient elastography for the detection of
liver biopsy in assessing fibrosis may be questioned because cirrhosis in clinical practice in a large cohort of consecutive
of sampling error and interobserver variability, which may patients with chronic liver disease.
lead to understaging of cirrhosis.6–9 Thus there is a need to
develop and validate non-invasive tests that can accurately PATIENTS AND METHODS
reflect the full spectrum of hepatic fibrosis, cirrhosis, and its Patients
severity in liver diseases. Between June 2003 and September 2004, all consecutive
Transient elastography (FibroScan; Echosens, Paris, patients with chronic liver diseases seen at the Hepatology
France) is a novel, rapid, and non-invasive technique which Unit of Haut-Lévêque Hospital (University Hospital of
measures liver stiffness.10 Briefly, this system is equipped Bordeaux, Pessac, France) were prospectively included.
with a probe consisting of an ultrasonic transducer mounted Determination of the aetiology of chronic liver disease was
on the axis of a vibrator. A vibration of mild amplitude and made using standard diagnostic criteria. Hepatitis C virus
low frequency is transmitted from the vibrator to the tissue (HCV) or hepatitis B virus (HBV) was diagnosed by
by the transducer itself. This vibration induces an elastic serological detection of hepatitis C antibodies (with positive
shear wave which propagates through the tissue. In the
meantime, pulse-echo ultrasonic acquisitions are performed Abbreviations: HCV, hepatitis C virus; HBV, hepatitis B virus; ROC,
to follow the propagation of the shear wave and measure its receiver operating characteristic; AUROC, area under the ROC curve;
velocity, which is directly related to tissue stiffness (or elastic AST, aspartate aminotransferase; ALT, alanine aminotransferase
www.gutjnl.com
404 Foucher, Chanteloup, Vergniol, et al
serum HCV-RNA by polymerase chain reaction) and hepatitis was calculated as the ratio of the number of successful
B surface antigen, respectively. Alcoholic liver disease was measurements over the total number of acquisitions. The
diagnosed in those with consumption of at least 40 g of results are expressed in kilopascal (kPa). Median value of the
alcohol daily for five years or more. All other diseases were successful measurements was kept as representative of liver
diagnosed as usual. The study protocol conformed to the stiffness. The whole examination duration was less than five
ethical guidelines of the 1975 Declaration of Helsinki. minutes. Only liver stiffness measurements obtained with at
Patients were enrolled after written informed consent was least five successful measurements and a success rate of at
obtained. All patients consented to the study. least 30% were considered reliable.
www.gutjnl.com
Transient elastography and cirrhosis 405
0.6
patients with viral and alcohol related cirrhosis, median liver
stiffness values were 23 kPa and 52.4 kPa, respectively
0.4
(p,0.001).
Moderate fibrosis or more
0.2 Severe fibrosis or more
Correlation between elastography measurement and
Cirrhosis
parameters of severity of cirrhosis
0 For all patients as well as for the subgroup of F3F4 patients,
0 0.2 0.4 0.6 0.8 1
1
_
specificity
as indicated in table 3, liver stiffness was significantly
(p,0.05) correlated with clinical parameters (past history
Figure 2 Receiver operator characteristic (ROC) curves for liver of bleeding varices, hepatocellular carcinoma, or ascites),
stiffness measurements for different fibrosis thresholds: moderate fibrosis biological parameters (platelet count, prothrombin time,
or more (F>F2), severe fibrosis or more (F>F3), and cirrhosis (F = 4). factor V, albumin, and total bilirubin) and morphological
www.gutjnl.com
406 Foucher, Chanteloup, Vergniol, et al
n r p Value n r p Value
parameters (oesophageal varices stage 2/3, ultrasonographic In the present study, cut off values for the diagnosis of
splenomegaly). In cirrhotic patients, liver stiffness was fibrosis were slightly different from those previously pub-
significantly (p,0.0001) correlated with Child-Pugh score lished.13 14 In published studies, for a diagnosis of fibrosis
(r = 0.517). >F2, cut off values ranged from 7.1 to 8.8 kPa.13 14 In our
study, this cut off was 7.2 kPa. For the diagnosis of fibrosis
Diagnosis accuracy of liver stiffness measurement in >F3, cut off values ranged from 9.5 to 9.6 kPa.13 14 In our
clinical practice study, this cut off was 12.5 kPa. Finally, for the diagnosis of
For patients with severe fibrosis or more (F>F3), AUROC cirrhosis, cut off values ranged from 12.5 to 14.6 kPa.13 14 In
values for the performances of the liver stiffness measure- our study, the cut off for diagnosis of cirrhosis was 17.6 kPa.
ments in detecting complications of cirrhosis are given in These differences could be due to the study population which
table 4. With a negative predictive value .90%, the cut off for comprised patients with chronic liver diseases of various
the presence of oesophageal varices stage 2/3 was 27.5 kPa, aetiologies. In the two previous studies, only patients with
for cirrhosis Child BC 37.5 kPa, for a past history of ascites chronic HCV infection were included. Secondly, in the two
49.1 kPa, for hepatocellular carcinoma 53.7 kPa, and for previously published studies, cut off values were chosen to
oesophageal bleeding 62.7 kPa (fig 3). According to these maximise the sum of sensitivity and specificity whereas in
negative predictive values, the usefulness of the liver stiffness this study we chose cut off values to have a positive predictive
measurements with FibroScan in clinical practice is indicated value of more than 90%, which favours specificity.
in fig 4. Cirrhotic patients with alcoholic liver disease had higher
liver stiffness values than cirrhotic patients with chronic
DISCUSSION hepatitis C. Indeed, patients with chronic hepatitis C are
The results of the present study conducted prospectively in a diagnosed at an early stage than alcoholic patients, with a
large cohort of patients with chronic liver disease showed histological diagnosis without clinical complications of
that transient elastography is an efficient technique for the cirrhosis. In contrast, patients with alcoholic disease are
diagnosis of cirrhosis and its severity. With a cut off value of diagnosed later, when clinical complications of cirrhosis
17.6 kPa, negative and positive predictive values for the occur.
diagnosis of cirrhosis were 92% and 91%, respectively. We To our knowledge, this study is also the first to compare
established the cut off value for complications of cirrhosis, liver stiffness measurement and fibrosis stage assessed on
with a negative predictive value of more than 90%. These cut liver biopsies in a large population of patients with chronic
off values were 27.5 kPa for the presence of oesophageal liver disease of various aetiologies. The diagnostic perfor-
varices stage 2/3, 37.5 kPa for cirrhosis Child BC, 49.1 kPa for mances for F>F2, F>F3, and F = F4 obtained in these
a past history of ascites, 53.7 kPa for hepatocellular different aetiological populations were similar to those
carcinoma, and 62.7 kPa for oesophageal bleeding. In clinical obtained in previously published studies conducted only in
practice, such results could be of major relevance for follow HCV patients.13 14 In our study, the proportion of patients
up of patients with severe fibrosis or cirrhosis. with advanced fibrosis stages (F>3) was higher than in the
Table 4 Diagnostic accuracy of liver stiffness for complications of cirrhosis (144 patients with F3F4 fibrosis)
AUROC (95% CI) Cut off (kPa) PPV NPV Sensitivity Specificity
AUROC, area under the ROC curve; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.
*F3 patients were classified as Child-Pugh A.
www.gutjnl.com
Transient elastography and cirrhosis 407
No oesophageal varices
stage 2 or 3
No Child-Pugh B or C
No hepatocellular carcinoma
www.gutjnl.com
408 Foucher, Chanteloup, Vergniol, et al
of cirrhosis was present in all three biopsy specimens in only 2 Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: results
of a large, prospective cohort study. Hepatology 1998;28:1687–95.
50% of patients.6 Similarly, Abdi and colleagues27 performed 3 Benvegnù L, Gios M, Boccato S, et al. Natural history of compensated viral
several post mortem biopsies and showed that the diagnosis cirrhosis: a prospective study on the incidence and hierarchy of major
of cirrhosis could be obtained from one biopsy specimen in complications. Gut 2004;53:744–9.
4 Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a
only 16 of 20 cases. According to Bedossa et al, sampling prospective nationwide survey. For the Group of Epidemiology of the French
variation in liver fibrosis is a significant limitation in the Association for the Study of the Liver (AFEF). Hepatology 2000;32:477–81.
assessment of fibrosis with liver biopsy.8 Thus some cirrhotic 5 Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med
2001;344:495–500.
patients are misclassified as F3 patients. To determine the 6 Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence
usefulness of liver stiffness measurements with FibroScan in on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet
clinical practice, to include all patients with cirrhosis, even 1986;1:523–5.
real cirrhotic patients with an incorrect F3 fibrosis at liver 7 Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation
in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol
biopsy examination, we evaluated the diagnostic accuracy of 2002;97:2614–18.
liver stiffness for complications of cirrhosis in F3F4 patients. 8 Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in
In patients with hepatocellular carcinoma, ultrasonogra- chronic hepatitis C. Hepatology 2003;38:1449–57.
9 Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on
phy was performed before FibroScan in order to evaluate liver histological evaluation of chronic viral hepatitis: the smaller the sample, the
stiffness in a part of the liver without hepatocellular milder the disease. J Hepatol 2003;39:239–44.
carcinoma. Therefore, tumour stiffness did not influence 10 Sandrin L, Tanter M, Gennisson JL, et al. Shear elasticity probe for soft tissues
with 1D transient elastography. Ultrason Ferroelectr Freq Control
the results of FibroScan. In this study, only a small number of 2002;49:436–46.
patients had hepatocellular carcinoma. Thus the role of 11 Saito H, Tada S, Nakamoto N, et al. Efficacy of non-invasive elastometry on
FibroScan in assessing the risk of hepatocellular carcinoma staging of hepatic fibrosis. Hepatol Res 2004;29:97–103.
12 Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new
needs further investigations. At last, in clinical practice (need non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol
for surgery, medical treatments, etc) the risk of cirrhosis 2003;29:1705–13.
decompensation could be excluded in patients with liver 13 Ziol M, Handra-Luca A, Kettaneh A, et al. Non-invasive assessment of liver
fibrosis by stiffness measurement: a prospective multicentre study in patients
stiffness measurements ,27 kPa (cut off value for Child A with chronic hepatitis C. Hepatology 2005;41:48–54.
stage). 14 Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient
In conclusion, liver stiffness measurement is a good elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in
chronic hepatitis C. Gastroenterology 2005;128:343–50.
method for the diagnosis of fibrosis and cirrhosis, irrespective 15 The French METAVIR Cooperative Study Group. Intraobserver and
of the cause of liver disease. Values in cirrhotic patients interobserver variations in liver biopsy interpretation in patients with chronic
ranged from 17.6 to 75.4 kPa. Liver stiffness measurement hepatitis C. Hepatology 1994;20:15–20.
may be accurate for assessing the severity of cirrhosis. 16 Saadeh S, Cammel G, Carey WD, et al. The role of liver biopsy in chronic
hepatitis C. Hepatology 2001;33:196–200.
However, a longitudinal cohort study needs to be performed 17 Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy.
to predict the complications of cirrhosis using FibroScan so Can J Gastroenterol 2000;14:543–8.
that screening for complications of cirrhosis, and close follow 18 Giannini E, Risso D, Botta F, et al. Validity and clinical utility of the aspartate
aminotransferase-alanine aminotransferase ratio in assessing disease severity
up, could be performed. and prognosis in patients with hepatitis C virus-related chronic liver disease.
Arch Intern Med 2003;163:218–24.
..................... 19 William ALB, Hoofnagle JH. Ratio of serum aspartate to alanine
Authors’ affiliations aminotransferase in chronic hepatitis. Relationship to cirrhosis.
Gastroenterology 1988;95:734–9.
J Foucher, E Chanteloup, J Vergniol, L Castéra, X Adhoute, J Bertet,
20 Pilette C, Oberti F, Aubé C, et al. Non-invasive diagnosis of esophageal
P Couzigou, Service d’Hépato-Gastroentérologie, Centre d’Investigation varices in chronic liver diseases. J Hepatol 1999;31:867–73.
de la Fibrose hépatique, Hôpital Haut Lévêque, CHU Bordeaux, Pessac, 21 Croquet V, Vuillemin E, Ternisien C, et al. Prothrombin index is an indirect
France marker of severe liver fibrosis. Eur J Gastroenterol Hepatol
B L Bail, INSERM E362 IFR 66, Université Victor Segalen, Bordeaux, 2002;14:1133–41.
France, and Laboratoire d’Anatomie-Pathologique, Hôpital Pellegrin, 22 Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can
predict both significant fibrosis and cirrhosis in patients with chronic hepatitis
CHU Bordeaux, Bordeaux, France C. Hepatology 2003;38:518–26.
V de Lédinghen, Service d’Hépato-Gastroentérologie, Centre 23 Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis
d’Investigation de la Fibrose hépatique, Hôpital Haut Lévêque, CHU in patients with hepatitis C virus infection: a prospective study. Lancet
Bordeaux, Pessac, France, and INSERM E362 IFR 66, Université Victor 2001;357:1069–75.
Segalen, Bordeaux, France 24 Aubé C, Oberti F, Korali N, et al. Ultrasonographic diagnosis of hepatic
fibrosis or cirrhosis. J Hepatol 1999;30:472–8.
Conflict of interest: None declared. 25 Chawla Y, Santa M, Dhiman RK, et al. Portal hemodynamics by duplex
doppler sonography in different grades of cirrhosis. Dig Dis Sci
1998;43:354–7.
26 Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal
REFERENCES varices in patients with primary sclerosing cholangitis. Hepatology
1 Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular 2004;39:204–10.
carcinogenesis in patients with chronic viral hepatitis: a prospective 27 Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver
observation of 2215 patients. J Hepatol 1998;28:930–8. biopsy. Arch Intern Med 1979;139:667–9.
www.gutjnl.com